Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Shares Outstanding (2010 - 2026)

Geron's (GERN) quarterly Shares Outstanding (Entity) came in at $642.5 million in Q2 2026, up 0.7% year-over-year from $638.0 million in Q2 2025, and little changed quarter-over-quarter from $639.9 million in Q4 2025.

Analysis

Geron (GERN) Shares Outstanding (2010 - 2026) Analysis & Trends

Geron has disclosed Shares Outstanding (Entity) across 17 years of filings, most recently posting $642.5 million for Q2 2026.

  • In Q2 2026, Shares Outstanding (Entity) rose 0.7% year-over-year to $642.5 million; the TTM figure through Jun 2026 stood at $642.5 million (up 0.7% YoY), while the FY2025 annual figure was $639.9 million, up 5.52% from the prior year.
  • Shares Outstanding (Entity) came in at $642.5 million for Q2 2026 at Geron, roughly flat from $639.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $642.5 million in Q2 2026 to a low of $377.4 million in Q1 2022.
  • Average Shares Outstanding (Entity) over 5 years is $544.1 million, with a median of $593.1 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Entity) soared 42.45% in 2023 and grew 0.7% in 2026.
  • Over 5 years, Shares Outstanding (Entity) stood at $390.3 million in 2022, then jumped by 39.63% to $544.9 million in 2023, then gained by 11.28% to $606.4 million in 2024, then advanced by 5.52% to $639.9 million in 2025, then increased by 0.41% to $642.5 million in 2026.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $642.5 million in Q2 2026, $639.9 million in Q4 2025, and $638.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 61.30 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 133.61 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 147.70 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 720.78 Mn
10 Geron 914.60 Mn 613.75 Mn - 670.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 670.04 Mn
Mar 31, 2026 666.66 Mn
Dec 31, 2025 666.66 Mn
Sep 30, 2025 667.10 Mn
Jun 30, 2025 666.17 Mn
Mar 31, 2025 665.91 Mn
Dec 31, 2024 646.03 Mn
Sep 30, 2024 662.16 Mn
Jun 30, 2024 653.90 Mn
Mar 31, 2024 603.49 Mn
Dec 31, 2023 570.65 Mn
Sep 30, 2023 579.51 Mn
Jun 30, 2023 547.28 Mn
Mar 31, 2023 544.46 Mn
Dec 31, 2022 380.78 Mn
Sep 30, 2022 405.24 Mn
Jun 30, 2022 403.87 Mn
Mar 31, 2022 332.07 Mn
Dec 31, 2021 327.63 Mn
Sep 30, 2021 328.93 Mn